Nanologica to Attend BIO-Europe Spring March 22-25 for Partnering Discussions
Nanologica will be attending BIO-Europe Spring, March 22-25, to meet with potential pharmaceutical partners regarding drug delivery applications using NLAB Spiro[®] and NLAB Silica™.Nanologica’s drug delivery platforms NLAB Spiro[®] and NLAB Silica™ consists of nanoporous particles where APIs can be placed inside the pores. By loading the API into the particles, Nanologica can overcome several of the challenges that prevent or limit effective treatment of many serious diseases. Some of the technical benefits of using Nanologica’s drug delivery platforms include improving solubility,